共 50 条
- [23] TARGETED INTENSIFICATION BY A PREPARATIVE REGIMEN FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) UTILIZING STANDARD-DOSE YTTRIUM-90 IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY (RIT) COMBINED WITH BEAM FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT). GROUPE D'ETUDE DES LYMPHOMES DE L'ADULTE (GELA) STUDY Z-BEAM 2 ANNALS OF ONCOLOGY, 2011, 22 : 169 - 169
- [28] Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High-Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) : 4317 - 4322
- [29] Prognostic Role of Host Immune Gene Polymorphisms for Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab and Chemotherapy. A Study Based on 554 Patients Included in the GELA (Groupe d'Etude des Lymphomes de l'Adulte) Prospective Multicentric Program LNH2003 BLOOD, 2011, 118 (21) : 1571 - 1571